1. Home
  2. ZNTL vs EVG Comparison

ZNTL vs EVG Comparison

Compare ZNTL & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$2.67

Market Cap

156.7M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

EVG

Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

HOLD

Current Price

$10.48

Market Cap

142.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZNTL
EVG
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
156.7M
142.9M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
ZNTL
EVG
Price
$2.67
$10.48
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
557.3K
41.0K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
47.87
N/A
EPS
N/A
N/A
Revenue
$67,425,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$10.25
52 Week High
$3.95
$11.45

Technical Indicators

Market Signals
Indicator
ZNTL
EVG
Relative Strength Index (RSI) 53.40 35.17
Support Level $1.29 N/A
Resistance Level $2.69 $11.16
Average True Range (ATR) 0.21 0.19
MACD -0.01 -0.01
Stochastic Oscillator 32.46 9.09

Price Performance

Historical Comparison
ZNTL
EVG

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: